A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis
Introduction: Pregnancy is widely accepted as a period when relapses of multiple sclerosis (MS) are decreased, with an increased risk of relapse in the first months postpartum. This systematic review evaluated relapses during pregnancy and postpartum, according to disease-modifying therapy (DMT) exp...
Saved in:
Main Authors: | Kerstin Hellwig, Elisabetta Verdun di Cantogno, Meritxell Sabidó |
---|---|
Format: | article |
Language: | EN |
Published: |
SAGE Publishing
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b7d6f9d4b983426f9486c0cb22ee7040 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
by: Lugaresi A, et al.
Published: (2013) -
The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results
by: Sandra Thiel, et al.
Published: (2021) -
Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
by: Dubey D, et al.
Published: (2015) -
Disease-modifying therapies in relapsing–remitting multiple sclerosis
by: Fabricio González-Andrade, et al.
Published: (2010) -
Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
by: Julie A Murphy, et al.
Published: (2010)